Skip to content

Investigator

Haitao Guo

UNIVERSITY OF PITTSBURGH AT PITTSBURGH · funded by NIAID, NCI

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$660k

Summed across those awards.

First award
Sep 10, 1997

Latest Jan 1, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    High throughput screening and preclinical development of HBV cccDNA inhibitors

    $228k

    Jan 1, 2024NIAIDUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 10995325 (opens the source filing in a new tab)

  2. R01

    Molecular Mechanisms of HBV cccDNA Formation

    $387k

    Mar 11, 2016NIAIDUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11122232 (opens the source filing in a new tab)

  3. P30

    Cancer Virology Program

    $45k

    Sep 10, 1997NCIUNIVERSITY OF PITTSBURGH AT PITTSBURGHNIH RePORTER · 11364448 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources